Top Markets
Coin of the day
DuoGenic StemCells corporation DuoGenic StemCells corporation

DuoGenic StemCells corporation

7607
Rank in Stocks #31252
Duogenic Stemcells Corporation is primarily engaged in the biotechnology and... Duogenic Stemcells Corporation is primarily engaged in the biotechnology and healthcare industries, offering a variety of services. Their core offerings include cell therapy and the development of closed-culture cell systems. The company was established on March 22, 2018, and its main corporate office is situated in Taichung, Taiwan.
Share Price
$0.37681848
Market Cap
$13.81M
Change (1 day)
-0.84%
Change (1 year)
10.95%
Country
TW
Trade DuoGenic StemCells corporation (7607)

Category

P/E ratio for DuoGenic StemCells corporation (7607)
P/E ratio as of 2026 TTM: 0
According to DuoGenic StemCells corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for DuoGenic StemCells corporation from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.